# PDCD2

## Overview
The PDCD2 gene encodes the programmed cell death 2 protein, which is a multifunctional protein involved in critical cellular processes such as ribosome biogenesis and cell cycle regulation. As a chaperone, the PDCD2 protein facilitates the assembly of the 40S ribosomal subunit by interacting with the 40S ribosomal protein uS5 (RPS2), ensuring its proper integration into ribosomal particles (LandryVoyer2020PDCD2). The protein's structure includes a TYPP domain and a MYND-type zinc finger, which are essential for its function and protein-protein interactions (LandryVoyer2020PDCD2). PDCD2 is also implicated in the regulation of the cell cycle, particularly in the transition from the G1 to S phase, and interacts with various proteins involved in transcriptional regulation and mRNA transport (Scarr2002PDCD2; Granier2014Conditional). Clinically, PDCD2 expression levels are significant in cancer, with alterations linked to conditions such as acute leukemia and lung carcinoma, highlighting its potential as a therapeutic target (Barboza2013PDCD2; Barboza2024Targeted).

## Structure
The PDCD2 protein contains a TYPP domain, which is crucial for its function as a chaperone for the 40S ribosomal protein uS5. This domain is structured around two similar repeats, each featuring GGxP and CxxC-like motifs, and includes a highly conserved glutamine residue. These repeats are separated by a MYND-type zinc finger, which facilitates protein-protein interactions (LandryVoyer2020PDCD2). The TYPP domain forms a globular structure, essential for PDCD2's interaction with uS5, and mutations in this domain disrupt the interaction (LandryVoyer2020PDCD2).

PDCD2 also undergoes alternative splicing, resulting in transcripts that skip certain exons, leading to truncated protein forms. These alternative transcripts lack the C-terminal domain, which may suggest a different biological function compared to the full-length protein (Mihola2007Conserved). The MYND domain is present in some splice variants, indicating its potential role in the truncated forms (Mihola2007Conserved). The protein's structure and domain composition suggest its involvement in ribosome biogenesis and potential regulatory roles in gene expression.

## Function
The PDCD2 gene encodes a protein that plays a crucial role in ribosome biogenesis and cell cycle regulation in healthy human cells. PDCD2 functions as a chaperone for the 40S ribosomal protein uS5 (RPS2), facilitating its proper assembly into the 40S ribosomal subunit. This interaction is essential for the synthesis of the small ribosomal subunit, as PDCD2 recognizes uS5 in the cytoplasm and escorts it to the nucleus for incorporation into ribosomes (LandryVoyer2020PDCD2). The PDCD2-uS5 complex is involved in the solubility, trafficking, and assembly of uS5, ensuring its proper integration into ribosomal particles (LandryVoyer2020PDCD2).

PDCD2 is also implicated in cell cycle regulation, particularly in the transition from the G1 to S phase. Its absence leads to increased levels of nuclear p53, a protein associated with cell cycle arrest and apoptosis, suggesting that PDCD2 may help regulate p53 activity to prevent unnecessary cell cycle arrest (Granier2014Conditional). PDCD2's role in ribosome biogenesis and cell cycle progression is critical for cellular proliferation and embryonic development, highlighting its importance in maintaining normal cellular functions (LandryVoyer2020PDCD2).

## Clinical Significance
Alterations in the expression of the PDCD2 gene have significant clinical implications, particularly in the context of cancer. High PDCD2 expression is characteristic of human hematopoietic progenitors and is notably elevated in acute leukemia, where it is associated with leukemic blasts. This elevated expression is linked to the primitive nature of malignant cells in acute leukemia, and a reduction in PDCD2 RNA levels post-treatment is correlated with remission, while persistent high levels may predict relapse (Barboza2013PDCD2). 

In lung carcinoma, PDCD2 influences cell proliferation by modulating the G1/S transition of the cell cycle, with its knockdown leading to slower proliferation and delayed cell cycle progression (Barboza2024Targeted). PDCD2 is also implicated in apoptosis regulation, particularly in lymphomas, where its expression is repressed by BCL6. Overexpression of PDCD2 can induce apoptosis through the activation of the caspase cascade, suggesting its potential role in lymphoma pathogenesis and as a target for novel therapies (Baron2010PDCD2).

In gastric gastrointestinal stromal tumors, PDCD2 acts as a putative tumor suppressor, with lower expression levels associated with decreased patient survival. Its interaction with NCoR1 and activation of the Smad signaling pathway further highlight its role in tumor suppression (Wang2015PDCD2).

## Interactions
PDCD2 interacts with several proteins and is involved in various cellular processes. It functions as a chaperone for the 40S ribosomal protein uS5 (RPS2), facilitating its incorporation into the 40S ribosomal subunit. This interaction is crucial for ribosome biogenesis and is evolutionarily conserved. PDCD2 forms complexes with uS5, involving either ZNF277 or PRMT3, although these proteins are not essential for ribosome biogenesis (LandryVoyer2020PDCD2).

PDCD2 also interacts with host cell factor 1 (HCF-1), acting as a negative regulator. This interaction involves the MYND domain of PDCD2, which associates with N-CoR/mSin3A corepressor complexes, suggesting a role in transcriptional regulation. PDCD2's interaction with HCF-1 is conserved across species and is implicated in cell cycle regulation (Scarr2002PDCD2).

Additionally, PDCD2 is linked to the regulation of mRNA transport and translation. It interacts with proteins such as FMRP/Fmr1 and NUFIP1/Nufip, which are involved in mRNA localization and translational repression. This suggests a role for PDCD2 in the regulation of specific mRNA-RNPs binding to the small ribosomal subunit (Minakhina2016Zfrp8PDCD2).


## References


[1. (Scarr2002PDCD2) Rebecca B Scarr and Phillip A Sharp. Pdcd2 is a negative regulator of hcf-1 (c1). Oncogene, 21(34):5245–5254, August 2002. URL: http://dx.doi.org/10.1038/sj.onc.1205647, doi:10.1038/sj.onc.1205647. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1205647)

[2. (Mihola2007Conserved) Ondrej Mihola, Jiri Forejt, and Zdenek Trachtulec. Conserved alternative and antisense transcripts at the programmed cell death 2 locus. BMC Genomics, January 2007. URL: http://dx.doi.org/10.1186/1471-2164-8-20, doi:10.1186/1471-2164-8-20. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-8-20)

[3. (Granier2014Conditional) Celine J. Granier, Wei Wang, Tiffany Tsang, Ruth Steward, Hatem E. Sabaawy, Mantu Bhaumik, and Arnold B. Rabson. Conditional inactivation of pdcd2 induces p53 activation and cell cycle arrest. Biology Open, 3(9):821–831, August 2014. URL: http://dx.doi.org/10.1242/bio.20148326, doi:10.1242/bio.20148326. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/bio.20148326)

[4. (Minakhina2016Zfrp8PDCD2) Svetlana Minakhina, Tatyana Naryshkina, Neha Changela, William Tan, and Ruth Steward. Zfrp8/pdcd2 interacts with rps2 connecting ribosome maturation and gene-specific translation. PLOS ONE, 11(1):e0147631, January 2016. URL: http://dx.doi.org/10.1371/journal.pone.0147631, doi:10.1371/journal.pone.0147631. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0147631)

[5. (Barboza2013PDCD2) Nora Barboza, Svetlana Minakhina, Daniel J. Medina, Binaifer Balsara, Sonya Greenwood, Lien Huzzy, Arnold B. Rabson, Ruth Steward, and Dale G. Schaar. Pdcd2 functions in cancer cell proliferation and predicts relapsed leukemia. Cancer Biology &amp; Therapy, 14(6):546–555, June 2013. URL: http://dx.doi.org/10.4161/cbt.24484, doi:10.4161/cbt.24484. This article has 20 citations.](https://doi.org/10.4161/cbt.24484)

[6. (Wang2015PDCD2) Wei Wang, Xiao-Wen Song, Xian-Min Bu, Ning Zhang, and Cheng-Hai Zhao. Pdcd2 and ncor1 as putative tumor suppressors in gastric gastrointestinal stromal tumors. Cellular Oncology, 39(2):129–137, November 2015. URL: http://dx.doi.org/10.1007/s13402-015-0258-0, doi:10.1007/s13402-015-0258-0. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13402-015-0258-0)

[7. (Baron2010PDCD2) Beverly W. Baron, Elizabeth Hyjek, Betty Gladstone, Michael J. Thirman, and Joseph M. Baron. Pdcd2, a protein whose expression is repressed by bcl6, induces apoptosis in human cells by activation of the caspase cascade. Blood Cells, Molecules, and Diseases, 45(2):169–175, August 2010. URL: http://dx.doi.org/10.1016/j.bcmd.2010.04.007, doi:10.1016/j.bcmd.2010.04.007. This article has 27 citations.](https://doi.org/10.1016/j.bcmd.2010.04.007)

[8. (LandryVoyer2020PDCD2) Anne-Marie Landry-Voyer, Danny Bergeron, Carlo Yague-Sanz, Breac Baker, and Francois Bachand. Pdcd2 functions as an evolutionarily conserved chaperone dedicated for the 40s ribosomal protein us5 (rps2). Nucleic Acids Research, 48(22):12900–12916, November 2020. URL: http://dx.doi.org/10.1093/nar/gkaa1108, doi:10.1093/nar/gkaa1108. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkaa1108)

[9. (Barboza2024Targeted) Nora Barboza, Daniel J. Medina, Garima Sinha, Evita Sadimin, Kuo-Chieh Lee, Gulam M. Rather, and Steven J. Greco. Targeted disruption of pdcd2 delays g1/s transition in lung carcinoma by inhibiting cyclin d1 transcription. International Journal of Translational Science, pages 53–76, February 2024. URL: http://dx.doi.org/10.13052/ijts2246-8765.2024.004, doi:10.13052/ijts2246-8765.2024.004. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.13052/ijts2246-8765.2024.004)